VBI Vaccines (NASDAQ:VBIV) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com started coverage on shares of VBI Vaccines (NASDAQ:VBIV – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Up 1.3 % VBI Vaccines stock opened at $0.59 on Friday. The stock has a market cap of […]
More Stories
“One Big Beautiful Bill” or “Debt Slavery Act”? Inside the High-Stakes Battle Over Trump’s Economic Agenda
By Stephen Zogopoulos, USNN World News On May 22, 2025, the U.S. House of Representatives narrowly passed the One Big...
Rubrik (NYSE:RBRK) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Rubrik (NYSE:RBRK – Free Report) had its target price hoisted by Wells Fargo & Company from $80.00 to $125.00 in...
TFR Capital LLC. Purchases New Stake in NVIDIA Co. (NASDAQ:NVDA)
TFR Capital LLC. purchased a new stake in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) during the 4th quarter,...
Alpha Wealth Funds LLC Takes $819,000 Position in NVIDIA Co. (NASDAQ:NVDA)
Alpha Wealth Funds LLC acquired a new stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) during the fourth quarter, according...
Wood Tarver Financial Group LLC Invests $590,000 in NVIDIA Co. (NASDAQ:NVDA)
Wood Tarver Financial Group LLC purchased a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) in the...
10,020 Shares in NVIDIA Co. (NASDAQ:NVDA) Purchased by Bannerman Wealth Management Group LLC
Bannerman Wealth Management Group LLC acquired a new position in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) in the...